The Japanese unit of Swiss pharmaceutical giant Novartis has been ordered to temporarily suspend its operations for failing to report drug side effects, revealed the health ministry. This is reportedly a first for a pharmaceutical firm operating in Japan. During the 15-day suspension, which is to start from March 5, the company will not be able to sell most of its drugs. Drug-makers are required to report serious side effects of any drugs to the ministry within ...
You have just read an article categorized health
titled Novartis Japan Hit With 15-day Suspension for Failing to Report Drug Side Effects.
Written by:
editor - Saturday, February 28, 2015
There are currently no comments for "Novartis Japan Hit With 15-day Suspension for Failing to Report Drug Side Effects"
Post a Comment